Pricing of separately billable ESRD drugs
House Committee on Ways and Means, Subcommittee on Health Testimony on Pricing of separately billable ESRD drugs
June 26, 2007, 1:15 p.m.
Robert A. Vito, Regional Inspector General for Evaluation and Inspections, Office of Inspector General, U.S. Department of Health and Human Services